93 related articles for article (PubMed ID: 6958088)
1. Changes in HLA-DR antigen expression on cultured human melanoma cells during theophylline treatment.
Liao SK; Kwong PC; Dent PB; Jerry LM
Tissue Antigens; 1982 Aug; 20(2):147-51. PubMed ID: 6958088
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.
Guerry D; Alexander MA; Herlyn MF; Zehngebot LM; Mitchell KF; Zmijewski CM; Lusk EJ
J Clin Invest; 1984 Jan; 73(1):267-71. PubMed ID: 6606651
[TBL] [Abstract][Full Text] [Related]
3. Extent of morphological differentiation of human melanoma cells reflected by HLA-DR antigen profiles.
Liao SK; Kawakubo Y; Smith JW; Singal DP; Wong YH
Prog Clin Biol Res; 1985; 172B():355-66. PubMed ID: 3857636
[No Abstract] [Full Text] [Related]
4. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S; Schmidt-Kessen A; Giuffrè L
Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
[TBL] [Abstract][Full Text] [Related]
5. Functional consequence of variation in melanoma antigen expression.
Zehngebot LM; Alexander MA; Guerry D; Cines DB; Mitchell K; Herlyn M
Cancer Immunol Immunother; 1983; 16(1):30-4. PubMed ID: 6605801
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
Alexander S; Hubbard SC; Strominger JL
J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR and melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant gamma-interferon: two-color flow cytometric analysis.
Kameyama K; Takezaki S; Kanzaki T; Nishiyama S
J Invest Dermatol; 1986 Sep; 87(3):313-8. PubMed ID: 3090158
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
9. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
10. Association of morphological differentiation with enhanced surface antigen expression and susceptibility to natural killer cell lysis in theophylline-treated human melanoma cells.
Liao SK; Kwong PC; Smith JW; Dent PB; Clark DA
J Biol Response Mod; 1983; 2(3):280-92. PubMed ID: 6644341
[TBL] [Abstract][Full Text] [Related]
11. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
12. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR antigen expression in primary melanomas of the skin.
Bröcker EB; Suter L; Sorg C
J Invest Dermatol; 1984 Mar; 82(3):244-7. PubMed ID: 6366074
[TBL] [Abstract][Full Text] [Related]
14. Selective extraction by 1-butanol of surface glycoprotein antigens from human melanoma cells.
Liao SK; Smith JW; Kwong PC
Cancer Immunol Immunother; 1984; 17(2):95-9. PubMed ID: 6205747
[TBL] [Abstract][Full Text] [Related]
15. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
17. HLA-D restriction of antigen-specific proliferative T cell responses. Inhibitory activity of antisera against HLA determinants or stimulatory antigen.
Thorsby E; Ferrone S; Nousiainen H; Hirschberg H
Tissue Antigens; 1983 Feb; 21(2):148-58. PubMed ID: 6189261
[TBL] [Abstract][Full Text] [Related]
18. Two-step enrichment of HLA-DR antigens from spent medium of human malignant melanoma culture by flotation and density separation procedures.
Khosravi MJ; Liao SK
Immunol Commun; 1983; 12(4):387-96. PubMed ID: 6579021
[TBL] [Abstract][Full Text] [Related]
19. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
20. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
